Jean-Charles Soria, Senior Vice President and Oncology Therapeutic Area Head at Amgen, shared a post on LinkedIn:
”Biomarker discovery through highly multiplexed tissue imaging is a critical step for precision oncology. It identifies complex patterns in tumors, paving the way for novel predictive biomarkers and treatment approaches.”
Highly Multiplexed Tissue Imaging in Precision Oncology and Translational Cancer Research
Authors: Alina Bollhagen, Bernd Bodenmiller.
